HBLRX | HBLVX | HBLRX / HBLVX | |
Total Expense Ratio | 1.28 | 0.56 | 229% |
Annual Report Gross Expense Ratio | 1.28 | 0.56 | 229% |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 0.138 | 0.387 | 36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.5B | 11.5B | 100% |
Annual Yield % from dividends | 2.96 | 3.63 | 81% |
Returns for 1 year | 2.79 | 3.57 | 78% |
Returns for 3 years | 3.34 | 5.60 | 60% |
Returns for 5 years | 14.41 | 18.24 | 79% |
Returns for 10 years | 25.70 | 33.43 | 77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FFA | 18.62 | 0.33 | +1.80% |
First Trust Enhanced Equity Income Fund | |||
TSPA | 33.75 | 0.59 | +1.78% |
T. Rowe Price US Equity Research ETF | |||
ECML | 28.54 | N/A | N/A |
Euclidean Fundamental Value ETF | |||
NDIA | 29.08 | -0.21 | -0.72% |
Global X India Active ETF | |||
RXD | 12.08 | -0.14 | -1.11% |
ProShares UltraShort Health Care |